{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:00:13Z","timestamp":1791486013319,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Excellence Research Program on Healthy Aging"},{"name":"Fondo de Alumnos 2017","award":["RU 1342\/2017"],"award-info":[{"award-number":["RU 1342\/2017"]}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["3170108"],"award-info":[{"award-number":["3170108"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.biopha.2018.12.087","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T12:09:13Z","timestamp":1545826153000},"page":"378-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Anti-aggregation effect on platelets of Indiplon a hypnotic sedative non-benzodiazepine drug"],"prefix":"10.1016","volume":"111","author":[{"given":"C.F.","family":"Burgos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sanch\u00e9z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt A","key":"10.1016\/j.biopha.2018.12.087_bib0005","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.phrs.2016.09.040","article-title":"Prevalence and prevention of cardiovascular disease and diabetes mellitus","volume":"113","author":"Balakumar","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"9990","key":"10.1016\/j.biopha.2018.12.087_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"Mega","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2018.12.087_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjh.12758","article-title":"Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation","volume":"165","author":"Machlus","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.087_bib0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3892\/etm.2012.477","article-title":"Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.)","volume":"3","author":"Palomo","year":"2012","journal-title":"Exp. Ther. Med."},{"issue":"11","key":"10.1016\/j.biopha.2018.12.087_bib0025","doi-asserted-by":"crossref","first-page":"e112741","DOI":"10.1371\/journal.pone.0112741","article-title":"Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling","volume":"9","author":"Fuentes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.12.087_bib0030","first-page":"1","article-title":"Adenosine A2A receptor agonists with potent antiplatelet activity","author":"Fuentes","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.biopha.2018.12.087_bib0035","first-page":"30","article-title":"International classification of sleep disorders, Diagnostic and coding manual","author":"A.A.o.S. Medicine","year":"2005","journal-title":"Am. Acad. Sleep Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.087_bib0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/sleep\/30.2.213","article-title":"Comorbidity of chronic insomnia with medical problems","volume":"30","author":"Taylor","year":"2007","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.biopha.2018.12.087_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J. Clin. Sleep Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.087_bib0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/sleep\/24.4.425","article-title":"Insomnia in men-a 10-year prospective population based study","volume":"24","author":"Janson","year":"2001","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2796.2002.00941.x","article-title":"Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population","volume":"251","author":"Mallon","year":"2002","journal-title":"J. Intern. Med."},{"issue":"7-8","key":"10.1016\/j.biopha.2018.12.087_bib0060","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1345\/aph.1K683","article-title":"Indiplon: A Nonbenzodiazepine Sedative\u2013Hypnotic for the Treatment of Insomnia","volume":"42","author":"Marrs","year":"2008","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.087_bib0065","first-page":"765","article-title":"Indiplon in the treatment of sleep disorders","volume":"3","author":"Lankford","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.087_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.105.096701","article-title":"Indiplon is a high-affinity positive allosteric modulator with selectivity for \u03b11 subunit-containing GABAA receptors","volume":"317","author":"Petroski","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7352","key":"10.1016\/j.biopha.2018.12.087_bib0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature10136","article-title":"Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation","volume":"474","author":"Lebon","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2018.12.087_bib0080","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"21","key":"10.1016\/j.biopha.2018.12.087_bib0085","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/09537104.2014.898747","article-title":"Strawberry extract presents antiplatelet activity by inhibition of inflammatory mediator of atherosclerosis (sP-selectin, sCD40L, RANTES, and IL-1beta) and thrombus formation","volume":"26","author":"Alarcon","year":"2015","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.biopha.2018.12.087_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.2011.08793.x","article-title":"Guidelines for the laboratory investigation of heritable disorders of platelet function","volume":"155","author":"Harrison","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2018.12.087_bib0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1963.sp007185","article-title":"The aggregation of blood platelets","volume":"168","author":"Born","year":"1963","journal-title":"J. Physiol. (Lond.)"},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0105","doi-asserted-by":"crossref","first-page":"e90699","DOI":"10.1371\/journal.pone.0090699","article-title":"Chlorogenic acid inhibits human platelet activation and thrombus formation","volume":"9","author":"Fuentes","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2018.12.087_bib0110","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1021\/jm4011669","article-title":"Adenosine A2A receptor as a drug discovery target","volume":"57","author":"de Lera Ruiz","year":"2014","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2018.12.087_bib0115","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1538-7836.2009.03455.x","article-title":"Calcium signaling in platelets","volume":"7","author":"Varga-Szabo","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.087_bib0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.104.071282","article-title":"Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor","volume":"311","author":"Sullivan","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.12.087_bib0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/09537100903047752","article-title":"Investigating GABA and its function in platelets as compared to neurons","volume":"20","author":"Kaneez","year":"2009","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.biopha.2018.12.087_bib0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00109-014-1140-7","article-title":"Characteristics of endogenous gamma-aminobutyric acid (GABA) in human platelets: functional studies of a novel collagen glycoprotein VI inhibitor","volume":"92","author":"Lin","year":"2014","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.12.087_bib0135","first-page":"I37","article-title":"Effect of diazepam and clonazepam on the function of isolated rat platelet and neutrophil","volume":"8","author":"Rajtar","year":"2002","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14728214.12.3.479","article-title":"Emerging adenosine receptor agonists","volume":"12","author":"Gao","year":"2007","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2018.12.087_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.087_bib0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0049-3848(01)00412-1","article-title":"Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect","volume":"105","author":"Anfossi","year":"2002","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.biopha.2018.12.087_bib0155","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI635","article-title":"Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs","volume":"101","author":"Minamino","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.087_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0197-0186(00)00034-6","article-title":"Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors","volume":"38","author":"Cunha","year":"2001","journal-title":"Neurochem. Int."},{"issue":"Web Server issue","key":"10.1016\/j.biopha.2018.12.087_bib0165","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gkr320","article-title":"ChemMine tools: an online service for analyzing and clustering small molecules","volume":"39","author":"Backman","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.12.087_bib0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.molmed.2015.09.002","article-title":"Emerging approaches to GPCR ligand screening for drug discovery","volume":"21","author":"Kumari","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2018.12.087_bib0175","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2741\/1939","article-title":"The role of ADP receptors in platelet function","volume":"11","author":"Murugappa","year":"2006","journal-title":"Front. Biosci."},{"issue":"7","key":"10.1016\/j.biopha.2018.12.087_bib0180","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2002-07-2209","article-title":"Platelet P-selectin facilitates atherosclerotic lesion development","volume":"101","author":"Burger","year":"2003","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.biopha.2018.12.087_bib0185","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0190","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1083\/jcb.101.3.880","article-title":"A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation","volume":"101","author":"Stenberg","year":"1985","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.biopha.2018.12.087_bib0195","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.jhh.1001447","article-title":"Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus","volume":"16","author":"Nomura","year":"2002","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0037-1614480","article-title":"Circulating platelets show increased activation in patients with acute cerebral ischemia","volume":"81","author":"Zeller","year":"1999","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.biopha.2018.12.087_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.88.1.37","article-title":"Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA","volume":"88","author":"Tschoepe","year":"1993","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.biopha.2018.12.087_bib0210","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1532-5415.1999.tb01288.x","article-title":"Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure","volume":"47","author":"Riondino","year":"1999","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0215","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0735-1097(00)00817-2","article-title":"Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy","volume":"36","author":"Moshfegh","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2018.12.087_bib0220","first-page":"924","article-title":"Pretreatment with oral anticoagulants decreases platelet activation in patients before and after percutaneous coronary intervention","volume":"88","author":"ten Berg","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.biopha.2018.12.087_bib0225","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/01.STR.0000013739.82306.7F","article-title":"Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation","volume":"33","author":"Kamath","year":"2002","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0230","first-page":"488","article-title":"Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin","volume":"88","author":"Storey","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.biopha.2018.12.087_bib0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-0037-1613448","article-title":"Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets","volume":"89","author":"Libersan","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0240","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH13-05-0386","article-title":"Protective mechanisms of adenosine 5\u2019-monophosphate in platelet activation and thrombus formation","volume":"111","author":"Fuentes","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.biopha.2018.12.087_bib0245","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH13-05-0386","article-title":"Protective mechanisms of adenosine 5\u2019-monophosphate in platelet activation and thrombus formation","volume":"111","author":"Fuentes","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biopha.2018.12.087_bib0250","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijcard.2017.08.006","article-title":"Guanosine exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling","volume":"248","author":"Fuentes","year":"2017","journal-title":"Int. J. Cardiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218344147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218344147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:33:02Z","timestamp":1760095982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218344147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":50,"alternative-id":["S0753332218344147"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.087","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-aggregation effect on platelets of Indiplon a hypnotic sedative non-benzodiazepine drug","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}